Australia
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
* SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials inAustralia in February 2025, with interim results expected by 2026. * Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding support from CEPI. * SK bioscience will respond to...
More than 96,000 respond to the first Global Cinema Federation Movie-Goer survey - 'New Box Office records will continue to be set, as supply meets demand'
* Customers largely prefer watching movies in cinemas, only 5% would rather
wait to watch on streaming
* Customers are seeking MORE action/adventures (59%) and comedies (53%) in
cinemas SYDNEY, Dec. 12, 2024 /PRNewswire/ -- The Global Cinema Federation
Alma Expands Injectables Presence in APAC with Profhilo® Launch in Thailand
CAESAREA, Israel, Dec. 12, 2024 /PRNewswire/ -- Alma Lasers
Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW
Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually SEOUL, South Korea, Dec. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer d...
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
* Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 * Appoints US-based Chief Commercial Officer, Andrew Udell * Xanamem's unique ability to control brain cortisol draws widespread coverage in the Australian media. SYDNEY, Dec. 9, 2024 /PRNewswire/ -- A...
Seeing Machines releases the 2023-24 Guardian Insights Report, highlighting alarming trends in driver fatigue and distraction from around the world
Over 11.6 million risky driving events recorded across 3.6 billion kilometres of travel in 12 months * More than 600,000 instances of mobile device use while driving were detected * On average, Guardian captured over 51 fatigue events per hour and more than 5 distracted driving events every mi...
AV-Comparatives Announces 2024 Phishing Test Results: Avast and McAfee Excel in Yearly Assessment
INNSBRUCK, Austria, Dec. 3, 2024 /PRNewswire/ -- AV-Comparatives, a leading independent organisation for IT security testing, has published the results of its comprehensive 2024 phishing protection tests. Over the year, 1,000 phishing URLs were tested in four quarterly evaluations to measure the ...
Panaya and Tritusa Join Forces to Enhance SAP Testing in Australia
This partnership brings together Panaya's robust AI-powered Smart Testing
platform and Tritusa's rich testing expertise to deliver superior testing
outcomes for Australian enterprises
HACKENSACK, N.J., Dec. 2, 2024 /PRNewswire/ -- Panaya
City of Kinston Enhances Utility Services with Hansen CIS Upgrade, Modernizing Customer Care and Billing
City of Kinston builds on its 26-year strong partnership with Hansen, upgrading its Customer Information System (CIS) to enhance customer care and billing experiences for its residents MELBOURNE, Australia, Nov. 21, 2024 /PRNewswire/ -- Hansen Technologies (ASX:HSN), a leading global provider of...
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Highlights: * Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS) * Neurizon's lead drug NUZ-001 and its major active metabolite significantly and dose-dependently prevented the aggregation of TAR DNA-binding protein 43 (TDP-43) by ~...
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
Highlights: * Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis * Orphan Designation offers 10 years of market exclusivity in Europe upon product approval, along with additional regulat...
Global Finals of the 17th Chinese Bridge--Chinese Proficiency Competition for Foreign Secondary School Students Successfully Held in Tianjin
TIANJIN, China, Oct. 30, 2024 /PRNewswire/ -- On the evening of October 28, the global finals and awarding ceremony for the 17th Chinese Bridge—Chinese Proficiency Competition for Foreign Secondary School Students and the 4th Chinese Bridge—Chinese Show for Foreign Primary School Students took pl...
$3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT
CRC-P GRANT SECURED BY TESSARA THERAPEUTICS, PSYLO, AND THE UNIVERSITY OF SYDNEY
TO ADVANCE BRAIN-REWIRING TREATMENTS FOR ADDICTION
BOULDER, Colo. , Oct. 28, 2024 /PRNewswire/ -- Tessara Therapeutics
MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia
SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 inAustralia, a self-developed oral antibacterial agent in development for the treatment of nontuberculous mycoba...
RateMyAgent Announces Strategic Acquisition of Curated Social, Bolstering Market Position and Expanding Offerings
MELBOURNE, Australia, Oct. 23, 2024 /PRNewswire/ -- Just six months after appointing a new CEO and rejuvenating its Board of Directors, RateMyAgent, a leading player in the real estate review and reputation management industry, is excited to announce that they have signed a binding agreement to a...
Doceree forms Strategic Partnership with The Ward Marketing Group to Strengthen Its Global Footprint; Expands into Australian Market
Expanding its reach from 22 markets to include Australia, Doceree partners with The Ward Marketing Group to enhance HCP-patient engagement in the region through innovative marketing solutions. SYDNEY, Oct. 23, 2024 /PRNewswire/ -- Doceree, the world's first global network of physician-only platf...
30,000 Marathon Enthusiasts Ignite the Beauty of Dalian with Their Run
DALIAN, China, Oct. 21, 2024 /PRNewswire/ -- At 7:30 on October 20th, the 34th Dalian Marathon kicked off, with 30,000 marathon enthusiasts successively dashing past the starting line. They crossed the city, running passionately in the cool weather, while being cheered on by enthusiastic citizens...
Universal Robots unveils its AI Accelerator, enabling a new wave of AI-powered cobot innovations
ODENSE, Denmark, Oct. 21, 2024 /PRNewswire/ -- Universal Robots, the Danish
collaborative robot (cobot) company, has today presented for the first time the
UR AI Accelerator
Copper-67 SAR-bisPSMA updates
SYDNEY, Oct. 16, 2024 /PRNewswire/ -- HIGHLIGHTS Cohort 4 - SECuRE Trial * The third participant of cohort 4 (multi-dose) of the SECuRE trial1 has now completed the Dose Limiting Toxicity (DLT) period after a second dose of 12GBq of67Cu-SAR-bisPSMA, following on from the announcement dated 1...
Getac to Demonstrate Edge-AI Capabilities through its X600 Rugged Mobile Workstation at IACP
News in brief: * Getac's Edge AI-based solution is designed for public safety agencies to quickly extract critical information from video footage and gain situational awareness during emergencies. * The basic solution provides edge computing work with the X600 rugged mobile workstation, whi...
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025
[Picked up by 288 media titles]
2025-12-08 11:00Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00